(Q37788232)

23 August 2017

Advances in methods for the determination of biologically relevant lipid peroxidation products (English)

1 reference

23 August 2017

5

Neven Zarkovic

1 reference

23 August 2017

Corinne M Spickett

1

1 reference

23 August 2017

Ingrid Wiswedel

series ordinal

2

1 reference

23 August 2017

Werner Siems

series ordinal

3

1 reference

23 August 2017

Kamelija Zarkovic

series ordinal

4

1 reference

23 August 2017

1 October 2010

1 reference

23 August 2017

Free Radical Research

1 reference

23 August 2017

44

1 reference

23 August 2017

10

1 reference

23 August 2017

1172-1202

1 reference

The measurement and mechanism of lipid peroxidation in biological systems

23 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Lipid peroxidation and biogenic aldehydes: from the identification of 4-hydroxynonenal to further achievements in biopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Role of oxidized low density lipoprotein in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Methods for the analysis of oxylipins in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Measurement of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Chlorinated lipids and fatty acids: an emerging role in pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Evaluation of products upon the reaction of hypohalous acid with unsaturated phosphatidylcholines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Chromatographic methods for the analyses of 2-halofatty aldehydes and chlorohydrin molecular species of lysophosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Characterization of linoleic acid nitration in human blood plasma by mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Fatty acid transduction of nitric oxide signaling: multiple nitrated unsaturated fatty acid derivatives exist in human blood and urine and serve as endogenous peroxisome proliferator-activated receptor ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Measuring free radical reactions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Exercise, free radicals, and lipid peroxidation in type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Manipulation of systemic oxygen flux by acute exercise and normobaric hypoxia: implications for reactive oxygen species generation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Determination of hydroperoxides in foods and biological samples by the ferrous oxidation-xylenol orange method: a review of the factors that influence the method's performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Determination of phospholipid hydroperoxides using luminol chemiluminescence--high-performance liquid chromatography.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Improved HPLC assay for lipid peroxides in human plasma using the internal standard of hydroperoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Malonaldehyde formation in intact platelets is catalysed by thromboxane synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Methods for determination of aldehydic lipid peroxidation products

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Analytical methods for trace levels of reactive carbonyl compounds formed in lipid peroxidation systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Quantification and significance of protein oxidation in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Validation of a novel ELISA for measurement of MDA-LDL in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Malondialdehyde-protein adducts in the spleens of aniline-treated rats: immunochemical detection and localization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Enzyme-linked immunosorbent assay for 4-hydroxynonenal-histidine conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Protein adducts generated from products of lipid oxidation: focus on HNE and one.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Proteomics identification of oxidatively modified proteins in brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxylipins: structurally diverse metabolites from fatty acid oxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Nonenzymatic lipid peroxidation reprograms gene expression and activates defense markers in Arabidopsis tocopherol-deficient mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Release of free F2-isoprostanes from esterified phospholipids is catalyzed by intracellular and plasma platelet-activating factor acetylhydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

The isoprostanes: unique bioactive products of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

The relationship between dose of vitamin E and suppression of oxidative stress in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

A nomenclature system for the isoprostanes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Human biochemistry of the isoprostane pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Key issues in F2-isoprostane analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Isoprostanes: formation, analysis and use as indices of lipid peroxidation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Isoprostanes: markers and mediators of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

F2-isoprostanes are not just markers of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Recent advances in the biochemistry and clinical relevance of the isoprostane pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Analysis of monohydroxyeicosatetraenoic acids and F2-isoprostanes as markers of lipid peroxidation in rat brain mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Flavanol-rich cocoa drink lowers plasma F(2)-isoprostane concentrations in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Evaluation of the postprandial effects of a fast-food meal on human plasma F(2)-isoprostane levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Isoprostanes: novel bioactive products of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Isoprostanes in fetal and neonatal health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single plasma sample

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxysterols and neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxysterols as markers of neurological disease--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxidized LDL and 4-hydroxynonenal modulate tyrosine kinase receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxysterols: Sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxysterols in biological systems: the gastrointestinal tract, liver, vascular wall and central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Activation of the mitochondrial pathway of apoptosis by oxysterols

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Cholesterol oxidation products in the vascular remodeling due to atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxysterols are increased in plasma of end-stage renal disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Cholesterol oxidation products and disease: an emerging topic of interest in medicinal chemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Analysis of neurosterols and neurosteroids by mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Bio-markers of lipid peroxidation in vivo: hydroxyoctadecadienoic acid and hydroxycholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Novel LC-MS/MS method for assay of 7alpha-hydroxy-4-cholesten-3-one in human plasma. Evidence for a significant extrahepatic metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Analysis of plasma cholesterol oxidation products using gas- and high-performance liquid chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Primary open-angle glaucoma: association with cholesterol 24S-hydroxylase (CYP46A1) gene polymorphism and plasma 24-hydroxycholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4beta-hydroxycholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Studies on the transcriptional regulation of cholesterol 24-hydroxylase (CYP46A1): marked insensitivity toward different regulatory axes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Metabolism of 4 beta -hydroxycholesterol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Novel pathways of bile acid metabolism involving CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxysterols in human circulation: which role do they have?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

On the origin of the cholestenoic acids in human circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Localization of sterol 27-hydroxylase immuno-reactivity in human atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Time course of the increase in 4beta-hydroxycholesterol concentration during carbamazepine treatment of paediatric patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxysterols and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Diagnostic use of cerebral and extracerebral oxysterols

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Increased plasma 7 beta-hydroxycholesterol concentrations in a population with a high risk for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Electrospray ionization-principles and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Mass spectrometry analysis of oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Effects of hypochlorous acid on unsaturated phosphatidylcholines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Hypochlorous acid-mediated generation of glycerophosphocholine from unsaturated plasmalogen glycerophosphocholine lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Radiation-induced free-radical transformation of phospholipids: MALDI-TOF MS study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Radiation-induced fragmentation of cardiolipin in a model membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Studies of phospholipid oxidation by electrospray mass spectrometry: from analysis in cells to biological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Identification of intact oxidation products of glycerophospholipids in vitro and in vivo using negative ion electrospray iontrap mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

The formation of phosphatidylcholine oxidation products by stimulated phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Myeloperoxidase-induced formation of chlorohydrins and lysophospholipids from unsaturated phosphatidylcholines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Electrospray ionization/tandem quadrupole mass spectrometric studies on phosphatidylcholines: the fragmentation processes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Determination of phosphatidylcholine monohydroperoxides using quadrupole time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Identification of 1-palmitoyl-2-linoleoyl-phosphatidylethanolamine modifications under oxidative stress conditions by LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Mass-spectrometric analysis of hydroperoxy- and hydroxy-derivatives of cardiolipin and phosphatidylserine in cells and tissues induced by pro-apoptotic and pro-inflammatory stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

The oxidative modification hypothesis of atherogenesis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Structural identification of a novel pro-inflammatory epoxyisoprostane phospholipid in mildly oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Epoxyisoprostane and epoxycyclopentenone phospholipids regulate monocyte chemotactic protein-1 and interleukin-8 synthesis. Formation of these oxidized phospholipids in response to interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Hydroxy alkenal phospholipids regulate inflammatory functions of endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

A novel family of atherogenic oxidized phospholipids promotes macrophage foam cell formation via the scavenger receptor CD36 and is enriched in atherosclerotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Identification of a novel family of oxidized phospholipids that serve as ligands for the macrophage scavenger receptor CD36

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Isolevuglandins, oxidatively truncated phospholipids, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Degradation of phospholipids by oxidative stress--exceptional significance of cardiolipin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Enhanced modification of cardiolipin during ischemia in the aged heart

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Applications of mass spectrometry in metabolomic studies of animal model and invertebrate systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

The emerging field of lipidomics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Sphingolipidomics: methods for the comprehensive analysis of sphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Shotgun lipidomics of cardiolipin molecular species in lipid extracts of biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Quantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Identification of oxidatively truncated ethanolamine phospholipids in retina and their generation from polyunsaturated phosphatidylethanolamines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Activated platelets and monocytes generate four hydroxyphosphatidylethanolamines via lipoxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Mass spectrometric analysis of HOCl- and free-radical-induced damage to lipids and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

High-resolution analysis by nano-electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for the identification of molecular species of phospholipids and their oxidized metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxidative lipidomics of apoptosis: quantitative assessment of phospholipid hydroperoxides in cells and tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

4-hydroxynonenal as a bioactive marker of pathophysiological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

4-Hydroxynonenal in the pathomechanisms of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

4-Hydroxynonenal as a second messenger of free radicals and growth modifying factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Role of aldehyde metabolizing enzymes in mediating effects of aldehyde products of lipid peroxidation in liver cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Selective cleavage of thioether linkage in proteins modified with 4-hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Studies on epitopes on low-density lipoprotein modified by 4-hydroxynonenal. Biochemical characterization and determination

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Detection of lipofuscin-like fluorophore in oxidized human low-density lipoprotein. 4-hydroxy-2-nonenal as a potential source of fluorescent chromophore

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

The distribution of 4-hydroxynonenal-modified proteins in gastric mucosa of duodenal peptic ulcer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

HNE-protein adducts formation in different pre-carcinogenic stages of hepatitis in LEC rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Differential sensitivity to 4-hydroxynonenal for normal and malignant mesenchymal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Enzyme immunoassay for a urinary metabolite of 4-hydroxynonenal as a marker of lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Immunohistochemical detection of lipid peroxidation products, protein-bound acrolein and 4-hydroxynonenal protein adducts, in actinic elastosis of photodamaged skin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Immunohistochemical appearance of HNE-protein conjugates in human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

4-hydroxynonenal and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Postischemic accumulation of lipid peroxidation products in the rat brain: immunohistochemical detection of 4-hydroxy-2-nonenal modified proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Low density lipoprotein undergoes oxidative modification in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (HNE) adducts with peptides and proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

4-Hydroxy-2-nonenal: a product and mediator of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Detection of 4-hydroxy-2-nonenal- and 3-nitrotyrosine-modified proteins using a proteomics approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Measurement of 4-hydroxynonenal in small volume blood plasma samples: modification of a gas chromatographic-mass spectrometric method for clinical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Urinalysis of 4-hydroxynonenal, a marker of oxidative stress, using stir bar sorptive extraction-thermal desorption-gas chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Characterization of 4-hydroxy-2-nonenal-modified peptides by liquid chromatography-tandem mass spectrometry using data-dependent acquisition: neutral loss-driven MS3 versus neutral loss-driven electron capture dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Rapid preparation of human urine and plasma samples for analysis of F2-isoprostanes by gas chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

On the Metabolism of Cholesterol in Rat Liver Homogenates. Bile Acids and Steroids 193

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Iron-induced carcinogenesis: the role of redox regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Aging and oxidative stress in progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxidative stress and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Toll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Immunological detection of 4-hydroxynonenal protein adducts in developing pontine and Purkinje neurons and in karyorrhexis in pontosubicular neuronal necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Cyp4a14 overexpression induced by hyperoxia in female CBA mice as a possible contributor of increased resistance to oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Oxidative stress in small-for-gestational age (SGA) term newborns and their mothers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Immunohistochemical localization of alpha-tocopherol transfer protein and lipoperoxidation products in human first-trimester and term placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

Automated Identification and Quantification of Glycerophospholipid Molecular Species by Multiple Precursor Ion Scanning

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715762.2010.498476

10.3109/10715762.2010.498476

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference